Hu抗体测定在副肿瘤性神经综合征随访中的价值

• 作 者: Llado′ A.pentier A.F.aus 姚庆和
• 机 构: Service of Neurology, Hospital Clinic, Villarroel 170, Barcelona 08036, Spain Dr.
• 出 处: 世界核心医学期刊文摘(神经病学分册)
• 发表日期: 2005年04期
• 关键词: 抗体测定 肿瘤性 神经 综合征 滴度 肿瘤进展 神经学 个月 抗体 Hu

The long- term evolution of Hu antibody (Hu- Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu- Ab titers in 35 patients with PNS with a median follow- up of 32 months (range 6 to 108 months). No correlation was observed between Hu- Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu- Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

The long-term evolution of Hu antibody (Hu- Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu- Ab titers in 35 patients with PNS with a median follow- up of 32 months (range 6 to 108 months). No correlation was observed between Hu- Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu- Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.